Total Payments
$1,916
2024 Payments
$373.37
Companies
25
Transactions
117
Medicare Patients
831
Medicare Billing
$32,193
Payment Breakdown by Category
Food & Beverage$1,916 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,916 | 117 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $447.84 | 29 | $0 (2024) |
| Novo Nordisk Inc | $289.91 | 21 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $192.60 | 9 | $0 (2024) |
| Amgen Inc. | $129.72 | 8 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $122.12 | 4 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $110.78 | 7 | $0 (2024) |
| PFIZER INC. | $82.39 | 5 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $81.27 | 5 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $58.12 | 4 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $45.87 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $373.37 | 24 | Novo Nordisk Inc ($165.71) |
| 2023 | $317.99 | 20 | ABBVIE INC. ($74.07) |
| 2022 | $659.87 | 45 | ABBVIE INC. ($182.57) |
| 2021 | $565.14 | 28 | AbbVie Inc. ($174.27) |
All Payment Transactions
117 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.88 | General |
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Cardio-renal | ||||||
| 10/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Biological | ||||||
| 09/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: VACCINES | ||||||
| 09/20/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.65 | General |
| 09/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Inflammation | ||||||
| 08/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Cardio-renal | ||||||
| 07/01/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Diabetes | ||||||
| 05/20/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Vaccines | ||||||
| 05/13/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Diabetes | ||||||
| 04/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Inflammation | ||||||
| 04/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $9.19 | General |
| Category: Obesity | ||||||
| 03/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Diabetes | ||||||
| 02/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Diabetes | ||||||
| 01/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Diabetes | ||||||
| 01/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Diabetes | ||||||
| 12/19/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 188 | 257 | $10,341 | $2,732 |
| 2022 | 10 | 221 | 410 | $38,379 | $9,874 |
| 2021 | 9 | 228 | 450 | $44,397 | $11,339 |
| 2020 | 9 | 194 | 397 | $37,763 | $8,248 |
Total Patients
831
Total Services
1,514
Medicare Billing
$32,193
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 32 | 65 | $2,837 | $672.75 | 23.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 28 | 44 | $1,760 | $577.28 | 32.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 23 | 27 | $1,638 | $444.42 | 27.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 30 | 39 | $936.00 | $296.79 | 31.7% |
| 86803 | Hepatitis c antibody measurement | Office | 2023 | 17 | 17 | $1,428 | $237.66 | 16.6% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 20 | 23 | $789.00 | $203.32 | 25.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 16 | 19 | $665.00 | $180.88 | 27.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 11 | $144.00 | $92.40 | 64.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 12 | $144.00 | $26.40 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 103 | $21,863 | $6,025 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 37 | $5,231 | $1,535 | 29.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 13 | 13 | $1,007 | $891.02 | 88.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 14 | $867.86 | $381.78 | 44.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 44 | 93 | $2,335 | $275.22 | 11.8% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 13 | 15 | $1,056 | $268.35 | 25.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 17 | 28 | $2,050 | $268.13 | 13.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 21 | $1,297 | $153.64 | 11.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 18 | 26 | $976.66 | $57.82 | 5.9% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 13 | 60 | $1,695 | $17.47 | 1.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 105 | $22,038 | $6,750 | 30.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 30 | 43 | $6,006 | $1,847 | 30.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 19 | $5,365 | $1,559 | 29.1% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 21 | 36 | $2,606 | $349.56 | 13.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 48 | 97 | $2,408 | $291.00 | 12.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 17 | 31 | $1,889 | $237.90 | 12.6% |
About Tracey Pick, ARNP
Tracey Pick, ARNP is a Specialist healthcare provider based in South Sioux City, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760444558.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tracey Pick, ARNP has received a total of $1,916 in payments from pharmaceutical and medical device companies, with $373.37 received in 2024. These payments were reported across 117 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,916).
As a Medicare-enrolled provider, Pick has provided services to 831 Medicare beneficiaries, totaling 1,514 services with total Medicare billing of $32,193. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Specialist, Specialist
- Location South Sioux City, NE
- Active Since 04/05/2006
- Last Updated 12/21/2022
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1760444558
Products in Payments
- NURTEC ODT (Drug) $203.39
- VRAYLAR (Drug) $196.89
- UBRELVY (Drug) $172.45
- Ozempic (Drug) $153.66
- Kerendia (Drug) $110.78
- Otezla (Drug) $102.45
- Rybelsus (Drug) $84.15
- BREZTRI (Drug) $79.53
- QULIPTA (Drug) $78.50
- FARXIGA (Drug) $73.54
- REXULTI (Drug) $45.87
- Livalo (Drug) $41.49
- GVOKE PFS (Drug) $38.91
- ELIQUIS (Drug) $30.11
- JARDIANCE (Drug) $29.78
- RYBELSUS (Drug) $29.01
- TRUMENBA (Biological) $28.65
- Veozah (Drug) $28.40
- TRADJENTA (Drug) $28.34
- EVENITY (Biological) $27.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.